Celgene Corporation competitors

Celgene Corporation's competitors include Shire, Amgen, Gilead Sciences, Sanofi and Regeneron Pharmaceuticals
Add company...
Celgene Corporation
Celgene Corporation is a biopharmaceutical company.
Shire
Shire is a specialty biopharmaceutical company.
Amgen
Amgen engages in the development of human therapeutic products in supportive of cancer care, inflammation, nephrology and bone diseases.
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Sanofi
Sanofi is a global life sciences company, focused on patient’s needs.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
Founding Date
Founding Date
1986
Founding Date
1986
Founding Date
1980
Founding Date
1987
Founding Date
2004
Founding Date
1988
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Summit, US HQ
Singapore, SG
Boudry, CH
Locations
Dublin, IE HQ
Buenos Aires, AR
Sydney, AU
Wien, AT
Bruxelles, BE
Chácara Santo Antonio (Zona Sul), BR
Sofia, BG
see more
Locations
Thousand Oaks, US HQ
Sydney, AU
North Ryde, AU
Vienna, AT
Brussels, BE
São Paulo, BR
Burnaby, CA
see more
Locations
Foster City, US HQ
Fremont, US
Oceanside, US
San Dimas, US
Branford, US
Seattle, US
Locations
Paris, FR HQ
Macquarie Park, AU
Ontario, CA
Beijing, CN
Hong Kong, HK
New Delhi, IN
Tokyo, JP
see more
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Greater London, GB
Rensselaer, US
Bernards, US
Employees
Employees
7,4675% increase
Employees
23,0444% decrease
Employees
20,8008% increase
Employees
9,000
Employees
106,859
Employees
6,20015% increase
Valuation ($)
Valuation ($)
58.9 b
Valuation ($)
52.4 b
Valuation ($)
127.8 b
Valuation ($)
98.8 b
Valuation ($)
118.9 b
Valuation ($)
39.4 b
Facebook likes
Facebook likes
6.6 k
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
5.4 k
Facebook likes
45.8 k
Facebook likes
3.9 k
Twitter followers
Twitter followers
19.1 k
Twitter followers
6.2 k
Twitter followers
65.4 k
Twitter followers
27 k
Twitter followers
101.3 k
Twitter followers
12.6 k

Financial

Revenue (est.)
Revenue (est.)
$13b (FY, 2017)
Revenue (est.)
$15.2b (FY, 2017)
Revenue (est.)
$23b (FY, 2016)
Revenue (est.)
$26.1b (FY, 2017)
Revenue (est.)
€37.1b (FY, 2015)
Revenue (est.)
$4.9b (FY, 2016)
Cost of goods
Cost of goods
$461m (FY, 2017)
Cost of goods
$4.7b (FY, 2017)
Cost of goods
$4.2b (FY, 2016)
Cost of goods
$4.4b (FY, 2017)
Cost of goods
€10.9b (FY, 2015)
Cost of goods
$194.6m (FY, 2016)
Gross profit
Gross profit
$12.5b (FY, 2017)
Gross profit
$10.5b (FY, 2017)
Gross profit
$18.8b (FY, 2016)
Gross profit
$21.7b (FY, 2017)
Gross profit
€26.1b (FY, 2015)
Gross profit
$4.7b (FY, 2016)
Net income
Net income
$2.9b (FY, 2017)
Net income
$4.3b (FY, 2017)
Net income
$7.7b (FY, 2016)
Net income
$4.6b (FY, 2017)
Net income
€4.4b (FY, 2015)
Net income
$895.5m (FY, 2016)

Operating

Countries
Countries
N/A
Countries
100 (FY, 2017)
Countries
N/A
Countries
30 (FY, 2016)
Countries
N/A
Countries
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
7 (FY, 2017)
Phase I Trials Products
N/A
Phase I Trials Products
3 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
12 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
15 (FY, 2017)
Phase III Trials Products
N/A
Phase III Trials Products
6 (FY, 2016)
Phase III Trials Products
7 (Y, 2016)
Phase III Trials Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
40 (FY, 2017)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
43 (Y, 2016)
Projects in R&D Pipeline
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 175.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 8.9m
For sources of this data, please see the company profileDownload Excel

View company profiles

Shire
HQ
Dublin, IE
Employees
23,044↓ 4% decrease

Shire is a specialty biopharmaceutical company.

View company
Amgen
HQ
Thousand Oaks, US
Employees
20,800↑ 8% increase

Amgen engages in the development of human therapeutic products in supportive of cancer care, inflammation, nephrology and bone diseases.

View company
Gilead Sciences
HQ
Foster City, US
Employees
9,000

Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.

View company
Sanofi
HQ
Paris, FR
Employees
106,859

Sanofi is a global life sciences company, focused on patient’s needs.

View company